SMAD3 and pulmonary fibrosis: Further expanding on its targeting role, a prior study also indicated miR-200b could ameliorate early pulmonary fibrosis induced by lipopolysaccharide by targeting ZEB1/2 through the p38 MAPK and TGF-β/smad3 axis [34].